Search Results - "Falk JA"

Refine Results
  1. 1

    The inspiratory capacity/totallungcapacityratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonarydisease by French A, Balfe D, Mirocha JM, Falk JA, Mosenifar Z

    “…Aimee French, David Balfe, James M Mirocha, Jeremy A Falk, Zab Mosenifar Cedars-Sinai Medical Center, Division of Pulmonary and Critical Care Medicine, Los…”
    Get full text
    Journal Article
  2. 2

    Treatment of Guillain-Barré syndrome induced by cyclosporine in a lung transplant patient by Falk, Jeremy A, Cordova, Francis C, Popescu, Anca, Tatarian, Gabriel, Criner, Gerard J

    “…We report the case of a 58-year-old man with severe chronic obstructive pulmonary disease who developed acute quadriparesis during the post-operative period…”
    Get more information
    Journal Article
  3. 3

    Management strategies and financial performance in rural and urban hospitals by Wang, B B, Wan, T T, Falk, J A, Goodwin, D

    Published in Journal of medical systems (01-08-2001)
    “…This study identifies the difference in financial performance between rural and urban hospitals and examines whether or not that difference may be attributed…”
    Get full text
    Journal Article
  4. 4

    16, 16 dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection by ABECASSIS, M, FALK, J. A, MAKOWKA, L, DINDZANS, V. J, FALK, R. E, LEVY, G. A

    Published in The Journal of clinical investigation (01-09-1987)
    “…16, 16 Dimethyl prostaglandin E2 (dmPGE2), a known cytoprotective agent, was examined for its ability to alter the course of fulminant hepatitis in an…”
    Get full text
    Journal Article
  5. 5

    The peripheral nerve allograft: a dose-response curve in the rat immunosuppressed with cyclosporin A by Bain, J R, Mackinnon, S E, Hudson, A R, Falk, R E, Falk, J A, Hunter, D A

    Published in Plastic and reconstructive surgery (1963) (01-09-1988)
    “…The potential use of peripheral nerve allografts would significantly improve the reconstructive potential for patients with major peripheral nerve deficits…”
    Get more information
    Journal Article
  6. 6

    Successful renal transplantation in patients with T-cell reactivity to donor by Cardella, C J, Falk, J A, Nicholson, M J, Harding, M, Cook, G T

    Published in The Lancet (British edition) (04-12-1982)
    “…A positive crossmatch due to T-cell reactivity against donor cells is considered a strong contraindication to renal transplantation because of the risk of…”
    Get more information
    Journal Article
  7. 7

    Lymphopenia and abnormal lymphocyte subsets in the "BB" rat: relationship to the diabetic syndrome by Poussier, P, Nakhooda, A F, Falk, J A, Lee, C, Marliss, E B

    Published in Endocrinology (Philadelphia) (01-05-1982)
    “…The "BB" rat spontaneously develops insulitis followed by impaired glucose tolerance (IGT) and/or an insulin-dependent diabetic syndrome like that in man. All…”
    Get more information
    Journal Article
  8. 8

    Allogeneic hepatocyte transplantation in the rat spleen under cyclosporine immunosuppression by Makowka, L, Lee, G, Cobourn, C S, Farber, E, Falk, J A, Falk, R E

    Published in Transplantation (01-11-1986)
    “…An innovative approach for stimulating the rapid growth of allogeneic hepatocytes implanted into splenic tissue with maintenance of the structural integrity is…”
    Get more information
    Journal Article
  9. 9

    Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation by Makowka, L, Rotstein, L E, Falk, R E, Falk, J A, Langer, B, Nossal, N A, Blendis, L M, Phillips, M J

    Published in Surgery (01-08-1980)
    “…This report describes the efficacy of syngeneic hepatocyte transplantation in an anoxic model and of xenogeneic (rabbit and porcine) hepatocyte transplantation…”
    Get more information
    Journal Article
  10. 10

    The characterization and partial purification of hepatocyte proliferation factor by Schwarz, L C, Makowka, L, Falk, J A, Falk, R

    Published in Annals of surgery (01-09-1985)
    “…This report presents further evidence that the liver is the source of the factor responsible for the initiation and/or stimulation of hepatic regeneration…”
    Get full text
    Journal Article
  11. 11

    16, 16 Dimethyl prostaglandin E sub(2) prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection by Abecassis, M, Falk, JA, Makowka, L, Dindzans, V J, Falk, R E, Levy, G A

    Published in The Journal of clinical investigation (01-01-1987)
    “…16, 16 Dimethyl prostaglandin E sub(2) (dmPGE sub(2)), a known cytoprotective agent, was examined for its ability to alter the course of fulminant hepatitis in…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Cellular Transplantation in the Treatment of Experimental Hepatic Failure by Makowka, L., Falk, R. E., Rotstein, L. E., Falk, J. A., Nossal, N., Langer, B., Blendis, L. M., Phillips, M. J.

    “…The survival of Lewis rats with D-galactosamine-induced fulminant hepatic failure was prolonged if they were given intraperitoneal injections of singlecell…”
    Get full text
    Journal Article
  15. 15

    The analysis with monoclonal antibodies of the heterogeneity of Ia glycoproteins on chronic lymphocytic leukemia cells by Addis, JB, Tisch, R, Falk, JA, Letarte, M

    Published in The Journal of immunology (1950) (01-11-1982)
    “…The accessible Ia molecules on the surface of chronic lymphocytic leukemia (CLL) cells were quantitated in the cellular radioimmunoassay with saturating…”
    Get full text
    Journal Article
  16. 16

    Comparison of the N-linked glycopeptides of DQw1 and DR1 molecules by Iturbe, S, Narasimhan, S, Merrick, JM, Falk, JA, Letarte, M

    Published in The Journal of immunology (1950) (15-06-1986)
    “…HLA class II molecules have been isolated from a [3H]mannose-labeled GM3104 B lymphoblastoid cell line with the phenotype DQw1, DR1. The DQw1 molecules were…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Combination therapy for resectable and unresectable adenocarcinoma of the pancreas by Falk, R E, Moffat, F L, Lawler, M, Heine, J, Makowka, L, Falk, J A

    Published in Cancer (01-02-1986)
    “…The current report summarizes our experience with 77 patients with cancer of the pancreas treated over 3.5 years. Patients were not assigned to a definite…”
    Get more information
    Journal Article
  19. 19

    Human Ia molecules carrying MT1 determinants: purification with a monoclonal antibody by Falk, J A, Lewis, W H, Letarte, M

    Published in Human immunology (01-08-1985)
    “…A monoclonal antibody 77.34, reactive with polymorphic HLA class II molecules, was produced. The allotype specificity of this IgG2a antibody was analyzed by…”
    Get more information
    Journal Article
  20. 20

    Protection of thermochemotherapeutic-induced lethal acute hepatic necrosis in the rat by 16,16-dimethyl prostaglandin E2 by Miyazaki, M, Makowka, L, Falk, R E, Falk, J A, McDonell, M, Venturi, D

    Published in The Journal of surgical research (01-05-1983)
    “…These studies further evaluate the hepatocytoprotective properties of 16,16-dimethyl prostaglandin E2 (dmPGE2) by assessing its effect on survival, liver…”
    Get more information
    Journal Article